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Aim: Published clinical series suggest the osteoodontokeratoprosthesis (OOKP) may have a lower
extrusion rate than current synthetic keratoprostheses. The OOKP is anchored in the eye wall by
autologous tooth. The authors’ aim was to compare adhesion, proliferation, and morphology for
telomerase transformed keratocytes seeded on calcium hydroxyapatite (the principal mineral constituent of
tooth) and materials used in the anchoring elements of commercially available synthetic keratoprostheses.
Methods: Test materials were hydroxyapatite, polytetrafluoroethylene (PTFE), polyhydroxyethyl metha-
crylate (HEMA), and glass (control). Cell adhesion and viability were quantified at 4 hours, 24 hours, and
1 week using a calcein-AM/EthD-1 viability/cytotoxicity assay. Focal contact expression and cytoskeletal
organisation were studied at 24 hours by confocal microscopy with immunoflourescent labelling. Further
studies of cell morphology were performed using light and scanning electron microscopy.
Results: Live cell counts were significantly greater on hydroxyapatite surfaces at each time point (p,0.04).
Dead cell counts were significantly higher for PTFE at 7 days (p,0.002). ß1 integrin expression was
highest on hydroxyapatite. Adhesion structures were well expressed in flat, spread out keratocytes on both
HA and glass. Keratocytes tended to be thinner and spindle shaped on PTFE. The relatively few keratocytes
visible on HEMA test surfaces were rounded and poorly adherent.
Conclusions: Keratocyte adhesion, spreading, and viability on hydroxyapatite test surfaces is superior to
that seen on PTFE and HEMA. Improving the initial cell adhesion environment in the skirt element of
keratoprostheses may enhance tissue integration and reduce device failure rates.
C
orneal opacification is the second most common cause
of world blindness affecting an estimated 10 million
people.1 Although endothelial failure is the most
common cause of corneal opacification in the developed
world, developing world populations—in which corneal
blindness is far more prevalent—are typically blind as a
result of ocular surface disease leading to corneal neovascu-
larisation and scarring.1 The prognosis for successful visual
rehabilitation with conventional corneal grafting in these
patients is often poor,2 and most of them have no access to
allograft donor material. Exciting progress is currently being
made in the development of tissue engineered alternatives to
cadaveric corneal donor material.3 But, as with conventional
allograft material, collagen based constructs may fail to
sustain a normal corneal epithelial phenotype or stromal
tissue clarity in a hostile ocular surface environment.
Techniques for promoting ocular surface regeneration4 5 that
could be used in tandem with corneal tissue replacement
currently require extensive laboratory back up and are not
available, even in the developed world, outside specialist
centres. For the foreseeable future, the best hope of widening
access to treatment for corneal blindness probably lies in the
development of an improved synthetic keratoprosthesis.6 7
Keratoprostheses incorporate a clear central optic and an
annular porous surround, or skirt element, designed to
provide tissue integration.7 The osteoodontokeratoprosthesis
(OOKP), consisting of an annular wafer of alveolar tooth
glued to a central polymethyl methacrylate optic has been
implanted since the 1960s with continuing relative success.
In particular, the device failure rate in association with poor
tissue integration for this keratoprosthesis would appear to
be significantly less than that for totally synthetic devices.8
Two totally synthetic keratoprostheses are currently available
commercially: the Legeais BioKpro III (FCI Ophthalmics,
Paris, France) and the AlphaCor (Argus Biomedical, Perth,
Australia). Published results from clinical series of patients
implanted with the Legeais BioKpro I and II suggest that up
to 40% of these devices fail within one year of implantation,9
with retraction of the surface tissues over the haptic element
of the device, retroprosthesis membrane formation, infection,
or aqueous leakage necessitating device removal or revision
of implantation. Results have not yet been published for the
Legeais BioKpro III, but this device incorporates the same
skirt material as earlier embodiments. Because inclusion
criteria vary between case series, direct comparison of results
between devices is difficult. But problems with poor tissue
integration may be equally common with the AlphaCor Kpro.
In a series of 40 implanted eyes followed for up to 36 months,
the overall rate of surgical revision for complications
associated with poor tissue integration was 30%.10 These
cases were a selected group comprised mainly of patients
with a normal ocular surface, and included 14 patients who
had not yet completed stage II of the implantation process in
which the surface tissues are opened over the device optic.
Most tissue integration problems are not clinically evident
until after this surgical stage.11 In contrast to these relatively
poor results for CE (Conformite´ Europe´ene) marked fully
synthetic Kpros, only five of 85 (5.8%) patients implanted
with the OOKP and followed for up to 16 years had clinical
problems with tissue integration.8 Indications for implanta-
tion in this series included severe ocular surface disease
Abbreviations: BSA, bovine serum albumin; Ethd-1, ethidium
homodimer-1; HEMA, polyhydroxyethyl methacrylate; OOKP,
osteoodontokeratoprosthesis; PBS, phosphate buffered saline; PTFE,
polytetrafluoroethylene; PHEMA, poly(2-hydroxyethyl methacrylate).
1356
www.bjophthalmol.com
 on 18 February 2008 bjo.bmj.comDownloaded from 
secondary to ocular cicatricial pemphigoid, Stevens-Johnson
syndrome, and previous chemical injury. The skirt materials
used as a porous framework for tissue integration are porous
polytetrafluoroethylene (PTFE) in the Legeais BioKpro III,
porous polyhydroxyethyl methacrylate (HEMA) in the
AlphaCor device, and autologous tooth (biological calcium
hydroxyapatite) in the OOKP.
Stable tissue integration is vital for keratoprosthesis
survival. Fibroblast invasion and matrix deposition has been
demonstrated in vivo in preclinical studies of porous HEMA12
and PTFE13 explanted from rabbit corneal stroma. But
comparative studies to determine whether the balance
between matrix synthesis and degradation may be modified
by the interfacial properties of different candidate kerato-
prosthesis materials have not been performed in vivo.
Sandeman et al14 have recently described a systematic
approach to the evaluation of novel keratoprosthesis materi-
als based on polyurethane based interpenetrating co-poly-
mers. Integral to the range of assays they describe are studies
of cell adhesion, viability, and morphology using a keratocyte
cell strain EK1.BR. As an initial step towards exploring the
cellular basis for differential extrusion rates observed
clinically between these leading contemporary keratopros-
theses, we performed comparative studies of cell adhesion,
survival, and morphology in standard culture conditions
using telomerase transformed EK1.BR keratocytes seeded on
plane surfaces of PTFE, HEMA, hydroxyapatite, and glass
(control).
Cellular interaction with the extracellular matrix is
mediated via integrins—that is, cell surface molecules which
link the extracellular matrix to the actin cytoskeleton.15).
Integrins are composed of an a and a b (18 a and 8 b
subunits) giving a diverse range of ab combinations with
their own binding specificity and signalling properties; many
of the most widely expressed integrins contain the b1
subunit. Clustering of integrins into supramolecular com-
plexes (with cytoskeletal proteins and signalling molecules)
is required to form focal contacts or adhesions. These serve as
attachment sites to the underlying ECM and can also act as
signalling centres regulating cell growth, survival, and gene
expression.16 Further comparative work was performed to
analyse the initial cellular interaction with the interfacial
protein layer coating candidate keratoprosthesis materials
incubated in serum enriched culture media by immunoflour-
escent labelling to characterise the actin cytoskeleton, focal
contact, and b1 integrin expression.
MATERIALS AND METHODS
Cells and materials
Telomerase transformed keratocytes were used throughout.
The EK1.BR embryonic keratocyte cell strain has previously
been characterised with respect to lifespan, fraction of
dividing cells, and maintenance of a keratocyte phenotype
in culture.17
pBABE-hTERT is a puromycin resistant amphotropic
retrovirus, based on a pBABE series vector backbone, that
expresses the catalytic subunit of human telomerase
(hTERT), and has been described previously.18 For retroviral
infections EK1.BR keratocytes were seeded at a density of
8.46104 cells in 60 mm diameter standard tissue culture
dishes. This seeding was performed about 24 hours before
infection so that the cultures were still substantially
subconfluent at the time of infection.
One hour before infection the cells were fed with fresh
medium containing 8 mg/ml of polybrene (Sigma, St Louis,
MO, USA). Two ml of supernatant from psiCRIP producer cell
lines containing either pBABE-hTERT or control (pBABE-
puro) retrovirus was then added to each 60 mm dish keeping
the polybrene concentration constant at 8 mg/ml. The cultures
were then incubated for 2 hours in a tissue culture incubator
at 37 C˚, after which time the retroviral supernatant was
diluted with fresh medium. After 24 hours the supernatant
was replaced with fresh medium and cells were incubated for
a further 48 hours. The cultures were then fed with selective
medium (MEM containing the supplements given above
together with 1.5 mg/ml puromycin). The concentration of
puromycin required to provide effective selection had been
determined by cytotoxicity studies undertaken in advance. At
each subsequent passage total cell numbers were estimated
and the population doublings estimated. EK1.BR were
considered immortal after 150 population doublings.
Test materials were hydroxyapatite (Plasma Biotal,
Tideswell, UK) produced by isostatic pressing hydroxyapatite
powder at a nominal pressure of 50 MPa into discs and
sintering the compacts at 1250 C˚, PTFE (Goodfellow
Cambridge Ltd, Huntingdon, UK); and HEMA (34% water)
(Cantor & Nissel, Northampton, UK). Glass coverslips were
used as a positive control material. The individual discs of
material were stored together at room temperature before
testing. All test materials were sterilised with ultraviolet
irradiation for one hour before use in the experiments. All
materials were used as either solid flat discs (hydroxyapatite
and glass coverslips) or as flat non-porous sheet material
(PTFE and HEMA).
Cell adhesion, proliferation, and viabili ty
A viability/cytotoxicity assay using calcein-AM and ethidium
homodimer-1 (EthD-1) (Molecular Probes, Eugene, OR,
USA) was used to quantify viable cell growth for cells seeded
at a standard concentration on each of the test materials at
4 hours, 24 hours, and 7 days. Calcein-AM is cleaved by
cellular esterases present within viable cells to form a
fluorescent green product which is membrane impermeable.
Ethidium homodimer-1 is a fluorescent red marker which
binds to nucleic acids and only passes through the
compromised membrane of non-viable cells.
10 mm diameter discs of each test material were placed in
the wells of a standard 12 well plate and sterilised by
ultraviolet irradiation. The discs were washed three times
then incubated in serum free MEM culture medium for
3 hours at 37 C˚ in 5% carbon dioxide/air. Telomerase
transformed EK1.BR keratocytes (56103 in 2 ml MEM
containing 10% FCS) were then seeded onto each of the
discs before further incubation at 37 C˚ in 5% carbon dioxide/
air. At 4 hours, 24 hours, and 1 week (n=3 per material for
each time point) culture medium was carefully removed from
the wells and the cells were washed in phenol red-free
medium. The discs were then incubated for 5 minutes at 37 C˚
in 5% carbon dioxide/air in phenol red-free MEM containing
calcein-AM (2 mM) and EthD-1 (1 mM) before inverted
placement in a new 12 well plate containing 1 ml of phenol
red-free MEM in each well. Cells adherent to the disc
surfaces were then viewed by fluorescence microscopy.
Sequential illumination at wavelengths of 500 nm and
625 nm was used to highlight calcein-AM positive (live)
and EthD-1 positive (dead) cells respectively. Live/dead cell
counts in five preselected fields per specimen were performed
at a magnification of610.
Cell morphology
Immunofluorescent labelling was used to examine surface
expression of integrin (b1), and focal contact/adhesion
formation. Organisation of the actin cytoskeleton was studied
using FITC-phalloidin staining. These studies were essentially
qualitative.
For immunofluorescent studies, primary labelling was with
(1:100) mouse anti-b1 integrin IgG (courtesy of Professor
Fiona Watt, Cancer Research, UK) and (1:50) Hvin 1 mouse
Keratoprosthesis skirt integration 1357
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antivinculin IgG (Sigma, Dorset, UK). Secondary labelling
was with (1:100) rhodamine conjugated donkey antimouse
IgG (Jackson ImmunoResearch Laboratories Inc, West Grove,
PA,USA). FITC-phalloidin (Molecular Probes, Eugene, OR,
USA) was used at a concentration of 1:10.
Discs of each material (n=4) were sterilised, washed,
seeded with a standard innoculum of test keratocytes, and
incubated for 24 hours as described above. After fixation by
immersion in 3% paraformaldehyde in phosphate buffered
saline (PBS) for 30 minutes, the test materials were washed
65 in PBS and quenched 62 for 10 minutes in 15 mM
glycine diluted in PBS.
Half the samples (n=2 per material) were dual labelled
with antivinculin and FITC-phalloidin after cell permeabili-
sation with 0.1% saponin diluted in PBS for 10 minutes.
Discs were blocked with 1% bovine serum albumin (BSA) in
PBS for 20 minutes before incubation with primary
antivinculin antibody for 2 hours, washing65 for 5 minutes,
and further incubation for 45 minutes with secondary
antibody plus FITC phalloidin—all in PBS/1% BSA/0.01%
saponin.
The remaining samples (n=2 per material) were blocked
with BSA and labelled with anti-b1 integrin primary antibody
and secondary antibody exactly as above, but without prior
saponin cell permeabilisation or the inclusion of saponin in
subsequent buffering solutions.
After final washing, five times for 5 minutes in 1% BSA
diluted in PBS (plus or minus 0.01% saponin) and twice with
PBS alone, the discs were then inverted, mounted, and wax
sealed onto glass slides. Subsequent imaging was performed
using a Bio-Rad radiance 2000 confocal microscope (Bio-Rad
Hercules, CA). We did not perform any immunofluorescent
labelling studies on poly(2-hydroxyethyl methacrylate)
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Figure 1 Live cell counts on test
materials at 4 hours, 24 hours, and
7 days: error bars are 26standard
error of the mean (95% confidence
limits). Cell adhesion to HEMA was too
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Figure 2 Dead cell counts on test
materials at 4 hours, 24 hours and
7 days: error bars are 26standard
error of the mean (95% confidence
limits). Cell adhesion to HEMA was too
poor to permit quantification.
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The number of viable cells at 24 hours on this material were
to few to obtain any useful images with the confocal laser.
Electron microscopy
Cells inoculated and cultured on test materials for 24 hours
as described above were fixed in 2% paraformaldehyde/2%
glutaraldehyde/0.1 M cacodylate for 30 minutes at room
temperature. Specimens were then treated with 1%
osmium/0.1 M cacodylate at 4 C˚ for 1 hour before dehydra-
tion in ethanol, washing in hexamethyl disilazane, and
drying by evaporation. After fixation, the discs were mounted
on stubs using conductive silver paint and sputter coated
with gold. Specimens were then examined in a JOEL 6100
(JOEL, Peabody, MA, USA) scanning electron microscope.
Statistics
SPSS version 11.5 was used to for analysis of variance to
examine differences between live/dead cell counts across
materials (SPSS Inc, Chicago, IL, USA). The Mann-Whitney
U test was used to examine differences in b1 integrin
expression across materials. Error bars on all graphs are
presented as 95% confidence limits (plus or minus 26stan-
dard error of the mean).
RESULTS
Cell adhesion, proliferation, and viablity
Live cell counts were significantly greater for hydroxyapatite
specimens at each time point than for the other test materials
(p=0.02 (4 hours), p=0.04 (24 hours), p=0.003 (1 week)
(fig 1). Cell counts increased between 24 hours and 7 days on
glass, hydroxyapatite, and PTFE, indicating that cells
proliferated on all these materials. However, dead cell counts
were significantly higher for PTFE than for other materials at
7 days (p=0.002) (fig 2), indicating that this material,
although supporting initial adhesion, was significantly more
cytotoxic than glass or hydroxyapatite.
Cell morphology
Qualitative observation of immunofluorescent labelled cells
(fig 3) suggested expression of ß1integrin on
hydroxyapatite.glass.PTFE. Stress fibres (phalloidin stain-
ing) were equally prominent on hydroxyapatite and glass but
less prominent on PTFE (fig 3). Focal adhesions (vinculin
immunostaining) were more prominent on hydroxyapatite
than on glass or PTFE (fig 3). Representative images shown
in figure 4 suggest that cell spreading was greater on
hydroxyapatite and glass, with cells on PTFE adopting a
more spindle shaped, elongated form.
Light microscopic observation during the cell adhesion,
proliferation, and viability assays suggested more rapid cell
spreading on hydroxyapatite than the other test materials
(fig 4). After 4 hours cells were round on the HEMA, a
mixture of round and spreading on glass and PTFE, and
mainly spreading on hydroxyapatite. At 24 hours cells on
HEMA were still mainly round with few cells spreading out;
but on glass, hydroxyapatite, and PTFE the cells were mainly
spread out. At 1 week there was a mass of cells on the glass,
hydroxyapatite, and PTFE; however the scant cell deposits on
HEMA were still round and poorly adherent. Scanning
electron microscopy, at 24 hours, was consistent with these
observations (fig 5). On hydroxyapatite cells were spread so
thinly that the surface texture of the test material was clearly
visible through flattened lamellipodia. Lamellipodia of cells
on glass were not as thin as those on hydroxyapatite, but
were, nevertheless, well spread and showed more filopodia
than cells cultured on hydroxyapatite. Cells cultured on PTFE





Figure 3 b1 integrin, F-actin and
vinculin distribution on test materials at
24 hours. Montage of confocal
micrographs of representative cells on
various test materials: b1 integrin
expression (immunofluorescent
labeling) on glass, hydroxyapatite, and
PTFE; stress fibre expression (phalloidin
staining) on glass, hydroxyapatite,
PTFE; and focal contact (vinculin)
expression on glass, hydroxyapatite,
and PTFE. Cell adhesion to HEMA
surfaces was too poor to obtain
confocal images.
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produced numerous long extensions, and were frequently
blebbing.
DISCUSSION
These basic studies of cell adhesion, proliferation, and
survival suggest that hydroxyapatite is superior, as an initial
adhesion environment for keratocytes, to inert plastics used
as a porous tissue integration framework in contemporary CE
marked keratoprosthesies. Cell adhesion to pHEMA was poor
and cell death was prominent on PTFE.
We used telomerase transformed keratocytes in an effort to
standardise our experimentation through the use of a cell line
with a near normal phenotype. Transduction of cells to
express the catalytic subunit of telomerase permits them to
retain their telomeres and divide indefinitely without global
alterations of gene expression produced by earlier methods of
cellular immortalisation.19 The use of telomerase transformed
cells is increasing in ophthalmic research20 21 and should help
to enhance both the reproducibility and biological validity of
experimental results.
Cells were derived from the previously characterised EK1-
BR1 human keratocyte strain.17 In the presence of serum, and
specifically TGF-b, keratocytes develop a myofibroblast
phenotype.22 Clinically, keratoprosthesis skirts may be colo-
nised by fibroblasts derived from sclera, or the overlying
mucous membrane flap. Although we have not performed
comparative studies, these cells have similar adhesion
structures, and it is unlikely that their behaviour would
differ significantly from keratocyte derived myofibroblasts.
The study was restricted to plane surfaces. Cells may
behave differently in colonising a 3D porous keratoprosthesis
skirt.7 Surface texture also exerts an important influence on
cell behaviour,23 and this was uncontrolled. Despite these
limitations, the fit between our principal findings and the
relatively good tissue integration observed clinically for the
OOKP8 is striking.
Our failure to observe cell adhesion on unmodified HEMA
surfaces is consistent with earlier published results.24 25
Peluso et al demonstrated human embryonic lung fibroblasts
plated on HEMA fail to spread after 24 hours and remain
spherical in shape, while those plated on modified HEMA





Figure 4 Light microscopy showing cell morphology on test materials. Montage of calcein-AM stained keratocytes illustrating cell morphology at
different time points (4 hours, 24 hours, 7 days) on glass (GL), hydroxyapatite (HA), HEMA, and PTFE.
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demonstrated good cell attachment and spreading.24
Sandeman et al also observed poor cellular attachment to
unmodified HEMA at 24 hours using the EK1.BR cell line
but showed spreading of cells if the HEMA was modified
with 15% phenoxyethyl methacrylate (PEM) or of 20%
2-(dimethylamino)ethyl methacrylate (DEM).25 Even at
1 week, little evidence of cellular attachment to unmodified
HEMA was observed. Although inferior to glass or hydro-
xyapatite, cell adhesion to PTFE surfaces was relatively good,
but characterised by high levels of cell death.
Failure of cell adhesion to pHEMA and relatively high
levels of cell death observed for PTFE may adversely influence
tissue integration for the AlphaCor and Legeais BioKpro 111
respectively. Both keratoprostheses have a published track
record of development which includes histological studies of
explants from intralamellar corneal implantation.26 27 These
studies, and others,7 demonstrate cellular ingrowth, collagen
and matrix deposition, but do not demonstrate matrix
stability. Future studies of gene expression focussing on
matrix synthesis and degradation may reveal important
differences among fibroblasts colonising different candidate
keratoprosthesis materials.
Hydroxyapatite is similar to the principal mineral consti-
tuent of bone and tooth, and is thought to promote
integration between hard and soft tissues by adsorbing
extracellular adhesion molecules in a 3D configuration that
preferentially exposes a high density of integrin binding
sites.28 We observed qualitatively greater b1 integrin expres-
sion in cells adherent to hydroxyapatite versus other test
materials. The strength of cell adhesion to a surface is
determined not only by the numbers of surface integrin
receptors, but also by their organisation. Integrins are
organised into oligomeric complexes, termed focal adhe-
sions/complexes, which link the extracellular matrix with the
actin cytoskeleton. Increased numbers of focal adhesions
observed in cells adherent to hydroxyapatite may account for
the increased adhesion to hydroxyapatite seen in live/dead
cell counts and the close apposition of keratocytes to the
hydroxyapatite shown by standard error of the mean.
A range of bioactive ceramic materials has been developed
to encourage bonding with soft tissues through an interfacial
layer of hydroxyapatite. Existing applications include ossi-
cular replacement, periodontal bone regeneration, and orbital
floor repair.28 Porous hydroxyapatite coral implants are
widely used in ophthalmology as post enucleation ball
implants.29 A keratoprosthesis with a coral skirt element
has also been described.30 However, a rigid hydroxyapatite
skirt could potentially lead to problems with device fracture,
and stress concentrations at the skirt/sclera interface could
encourage tissue breakdown. Although bioactive ceramics are
available as resorbable gels and metallic surface coatings,
coating a flexible polymer is less easy. The ideal keratoprosth-
esis would have a modulus of elasticity similar to the eye
wall.7 Flexible polymer surfaces incorporating integrin adhe-
sion ligands such as the RGD or YIGSR motif have recently
been developed.31 A logical future extension of our study
would encompass these materials.
The selection of inert plastic materials such as PTFE and
HEMA as keratoprosthesis skirt materials has been based on
their record of safe implantation rather than any special
merit as an interfacial surface to promote normal tissue
differentiation.7 27 We have demonstrated that hydroxy-
apatite is a superior starting adhesion environment for
keratocytes. This may help to explain relatively low extrusion
rates observed clinically for the OOKP,8 and suggests that
material selection for the next generation of keratoprostheses
should move away from inert plastics towards materials
designed to promote normal adhesion and differentiation in
contacting cells.
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Figure 5 Scanning electron microscopy showing cell morphology on
test materials. Montage of scanning electron micrographs showing
keratocyte morphology at 24 hours on glass, HA, and PTFE.
Bar = 10 mm.
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